Monday, April 8, 2019 Daily Archives

Sangamo ‘excited’ about Thermo’s takeover of CDMO partner Brammer

by

Sangamo Therapeutics has secured access to large-scale AAV manufacturing through long-term partner Brammer Bio, a gene therapy CDMO set to be bought by Thermo Fisher. Sangamo Therapeutics has several gene therapy candidates moving through the clinic, including its own programs for inherited metabolic diseases and partnered programs in hematology with Pfizer and Sanofi. To support these, the firm has broadened out its manufacturing strategy by securing access to large-scale adeno-associated virus (AAV) manufacturing through an option agreement with contract development…

April 8, 2019

Spin-out Cellular Highways looks to next-generation cell-sorting

by

There is no cell purification technology that allows the selection of cells based on several molecular markers at the same time while processing large batches of cells. That is until the VACS platform, new entity Cellular Highways claims. Tech firm TTP has invested £1.7 million ($2.2 million) in its spin-out firm Cellular Highway in efforts to commercialize the Vortex-Actuated Cell Sorting (VACS) platform. Bioprocess Insider (BI) spoke to Salman Samson Rogers (SSR), CEO of the new entity to find out…

April 8, 2019